Cargando…
Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial
The COVID-19 evolution depends on immunological capacity. The global hospital mortality rate is 15–20%, but in México it is 46%. There are several therapeutic protocols, however, integral nutrition is not considered. In this study, a Nutritional Support System (NSS) was employed to increase survival...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835093/ https://www.ncbi.nlm.nih.gov/pubmed/35162195 http://dx.doi.org/10.3390/ijerph19031172 |
_version_ | 1784649344871301120 |
---|---|
author | Leal-Martínez, Fernando Abarca-Bernal, Lorena García-Pérez, Alejandra González-Tolosa, Dinnaru Cruz-Cázares, Georgina Montell-García, Marco Ibarra, Antonio |
author_facet | Leal-Martínez, Fernando Abarca-Bernal, Lorena García-Pérez, Alejandra González-Tolosa, Dinnaru Cruz-Cázares, Georgina Montell-García, Marco Ibarra, Antonio |
author_sort | Leal-Martínez, Fernando |
collection | PubMed |
description | The COVID-19 evolution depends on immunological capacity. The global hospital mortality rate is 15–20%, but in México it is 46%. There are several therapeutic protocols, however, integral nutrition is not considered. In this study, a Nutritional Support System (NSS) was employed to increase survival and reduce mortality in patients with stage III COVID-19. A randomized, blinded, controlled clinical trial was performed. Eighty patients (aged 30 to 75 years, both sexes) were assigned to (1) “Control Group” (CG) hospital diet and medical treatment or (2) “Intervention Group” (IG) hospital diet, medical treatment, and the NSS (vitamins, minerals, fiber, omega-3, amino acids, B-complex, and probiotics). IG significantly increased survival and reduced mortality compared to CG (p = 0.027). IG decreased progression to Mechanical Ventilation Assistance (MVA) by 10%, reduced the intubation period by 15 days, and increased survival in intubated patients by 38% compared to CG. IG showed improvement compared to CG in decrease in supplemental oxygen (p = 0.014), the qSOFA test (p = 0.040), constipation (p = 0.014), the PHQ-9 test (p = 0.003), and in the follow-up, saturation with oxygen (p = 0.030). The NSS increases survival and decreases mortality in patients with stage III COVID-19. |
format | Online Article Text |
id | pubmed-8835093 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88350932022-02-12 Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial Leal-Martínez, Fernando Abarca-Bernal, Lorena García-Pérez, Alejandra González-Tolosa, Dinnaru Cruz-Cázares, Georgina Montell-García, Marco Ibarra, Antonio Int J Environ Res Public Health Article The COVID-19 evolution depends on immunological capacity. The global hospital mortality rate is 15–20%, but in México it is 46%. There are several therapeutic protocols, however, integral nutrition is not considered. In this study, a Nutritional Support System (NSS) was employed to increase survival and reduce mortality in patients with stage III COVID-19. A randomized, blinded, controlled clinical trial was performed. Eighty patients (aged 30 to 75 years, both sexes) were assigned to (1) “Control Group” (CG) hospital diet and medical treatment or (2) “Intervention Group” (IG) hospital diet, medical treatment, and the NSS (vitamins, minerals, fiber, omega-3, amino acids, B-complex, and probiotics). IG significantly increased survival and reduced mortality compared to CG (p = 0.027). IG decreased progression to Mechanical Ventilation Assistance (MVA) by 10%, reduced the intubation period by 15 days, and increased survival in intubated patients by 38% compared to CG. IG showed improvement compared to CG in decrease in supplemental oxygen (p = 0.014), the qSOFA test (p = 0.040), constipation (p = 0.014), the PHQ-9 test (p = 0.003), and in the follow-up, saturation with oxygen (p = 0.030). The NSS increases survival and decreases mortality in patients with stage III COVID-19. MDPI 2022-01-21 /pmc/articles/PMC8835093/ /pubmed/35162195 http://dx.doi.org/10.3390/ijerph19031172 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Leal-Martínez, Fernando Abarca-Bernal, Lorena García-Pérez, Alejandra González-Tolosa, Dinnaru Cruz-Cázares, Georgina Montell-García, Marco Ibarra, Antonio Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial |
title | Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial |
title_full | Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial |
title_fullStr | Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial |
title_full_unstemmed | Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial |
title_short | Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial |
title_sort | effect of a nutritional support system to increase survival and reduce mortality in patients with covid-19 in stage iii and comorbidities: a blinded randomized controlled clinical trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835093/ https://www.ncbi.nlm.nih.gov/pubmed/35162195 http://dx.doi.org/10.3390/ijerph19031172 |
work_keys_str_mv | AT lealmartinezfernando effectofanutritionalsupportsystemtoincreasesurvivalandreducemortalityinpatientswithcovid19instageiiiandcomorbiditiesablindedrandomizedcontrolledclinicaltrial AT abarcabernallorena effectofanutritionalsupportsystemtoincreasesurvivalandreducemortalityinpatientswithcovid19instageiiiandcomorbiditiesablindedrandomizedcontrolledclinicaltrial AT garciaperezalejandra effectofanutritionalsupportsystemtoincreasesurvivalandreducemortalityinpatientswithcovid19instageiiiandcomorbiditiesablindedrandomizedcontrolledclinicaltrial AT gonzaleztolosadinnaru effectofanutritionalsupportsystemtoincreasesurvivalandreducemortalityinpatientswithcovid19instageiiiandcomorbiditiesablindedrandomizedcontrolledclinicaltrial AT cruzcazaresgeorgina effectofanutritionalsupportsystemtoincreasesurvivalandreducemortalityinpatientswithcovid19instageiiiandcomorbiditiesablindedrandomizedcontrolledclinicaltrial AT montellgarciamarco effectofanutritionalsupportsystemtoincreasesurvivalandreducemortalityinpatientswithcovid19instageiiiandcomorbiditiesablindedrandomizedcontrolledclinicaltrial AT ibarraantonio effectofanutritionalsupportsystemtoincreasesurvivalandreducemortalityinpatientswithcovid19instageiiiandcomorbiditiesablindedrandomizedcontrolledclinicaltrial |